NEW YORK, Jan. 27, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT).Shareholders who purchased shares of APLT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/applied-therapeutics-inc-loss-submission-form/?id=124870&from=4CLASS PERIOD: J ...

Lawsuit Overview - A securities class action lawsuit has been filed against Applied Therapeutics Inc (NASDAQ: APLT) in the United States District Court for the Southern District of New York [1] - The lawsuit is on behalf of investors who purchased or acquired Applied Therapeutics securities between January 3, 2024, and December 2, 2024 [1] - The lead plaintiff deadline is February 18, 2025 [1] Allegations - The complaint alleges that Applied Therapeutics made false and/or misleading statements and/or failed to disclose that the company was not adhering to trial protocol and good clinical practices for its drug candidate, govorestat [2] - This alleged misconduct created a severe risk that the trial data would be rejected by the FDA in the context of a New Drug Application [2] Lead Plaintiff Process - Applied Therapeutics investors may seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP or other counsel by February 18, 2025 [3] - The lead plaintiff is typically the investor or small group of investors with the largest financial interest who are also adequate and typical of the proposed class of investors [3] - The lead plaintiff selects counsel to represent the lead plaintiff and the class, and these attorneys, if approved by the court, are lead or class counsel [3] Law Firm Information - Kessler Topaz Meltzer & Check, LLP is prosecuting the class action and encourages Applied Therapeutics investors who have suffered significant losses to contact the firm directly [4] - The firm has a global reputation for excellence and has recovered billions of dollars for victims of fraud and other corporate misconduct [4] - The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP [4]

NEW YORK, Jan. 23, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT).Shareholders who purchased shares of APLT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/applied-therapeutics-inc-loss-submission-form/?id=124341&from=4 CLASS PERIOD: ...

Shareholders of Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT ...

APLT LAWSUIT ALERT: Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline ...

NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ: APLT) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc. Investors have until February 18, 2025, to a ...

Levi & Korsinsky Notifies Shareholders of Applied Therapeutics, Inc.(APLT) of a Class Action Lawsuit and an Upcoming Deadline ...

NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ:APLT), a biopharmaceutical company dedicated to creating transformative treatments for rare disease, today announced the appointment of Reena Thomas Colacot as Vice President and Head of Quality. Ms. Colacot joins Applied with over 25 years of quality leadership experience across the biopharmaceutical and medical device industries. In this newly created role, she will report directly to the executive leadership team and Executive ...

APLT DEADLINE: The February 18 Applied Therapeutics, Inc. Class Action Deadline is Approaching - Contact BFA Law if You Suffered Losses ...

Investors in Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT ...